Cancer screening in Canada: What's in, what's out, what's coming.
作者信息
Chaput Genevieve, Del Giudice M Elisabeth, Kucharski Ed
机构信息
Attending physician in the Departments of Family Medicine, Secondary Care and Oncology at McGill University Health Centre and McGill University in Montreal, Que, and Interim Medical Director of Maison de soins palliatifs de Vaudreuil-Soulanges in Hudson, Que.
A family physician with the Sunnybrook Academic Family Health Team, Assistant Professor in the Department of Family and Community Medicine at the University of Toronto in Ontario, and Regional Primary Care Cancer Screening Lead in Toronto Central North at Ontario Health-Cancer Care Ontario.
出版信息
Can Fam Physician. 2021 Jan;67(1):27-29. doi: 10.46747/cfp.670127.
Abstract
摘要
相似文献
1
Cancer screening in Canada: What's in, what's out, what's coming.加拿大的癌症筛查：哪些被纳入，哪些被排除，哪些即将到来。
Can Fam Physician. 2021 Jan;67(1):27-29. doi: 10.46747/cfp.670127.
2
Cervical cancer screening: what's new and what's coming?宫颈癌筛查：有哪些新进展和新动向？
Cleve Clin J Med. 2013 Mar;80(3):153-60. doi: 10.3949/ccjm.80a.12092.
3
Update on health care in Canada: what's right, what's wrong, what's left.加拿大医疗保健最新情况：哪些方面做得对，哪些方面存在问题，以及未来走向。
J Public Health Policy. 1998;19(3):267-88.
4
What's needed for Canada's cervical cancer endgame?加拿大实现宫颈癌防治目标需要什么？
CMAJ. 2019 Apr 29;191(17):E481. doi: 10.1503/cmaj.71914.
5
Editor's Report: What's Now, What's New, and What's Coming.编辑报告：现状、新进展与未来趋势
J Vasc Interv Radiol. 2018 Feb;29(2):147-148. doi: 10.1016/j.jvir.2017.12.014.
6
Cardiovascular product update and evaluation. What's hot, what's not, what's in, what's out.心血管产品更新与评估。热门产品、冷门产品、流行产品、淘汰产品。
J Interv Cardiol. 1994 Apr;7(2):203-4. doi: 10.1111/j.1540-8183.1994.tb00905.x.
7
Cardiovascular product update and evaluation. What's hot, what's not, what's in, what's out.心血管产品更新与评估。热门产品、冷门产品、流行产品、淘汰产品。
J Interv Cardiol. 1992 Mar;5(1):67-8. doi: 10.1111/j.1540-8183.1992.tb00827.x.
8
Six screening tests for adults: What's recommended? What's controversial?
Cleve Clin J Med. 2014 Nov;81(11):652-5. doi: 10.3949/ccjm.81gr.14003.
9
A commentary on the evolution of NIH: what's in, what's out, what's hot, what's not.关于美国国立卫生研究院发展历程的述评：哪些入选，哪些落选，哪些热门，哪些冷门。
Integr Physiol Behav Sci. 1998 Apr-Jun;33(2):115-7. doi: 10.1007/BF02688652.
10
What's Lost in What's Missing: A Thoughtful Approach to Missing Data in the National Cancer Database.缺失数据中遗漏了什么：对国家癌症数据库中缺失数据的深入探讨方法。
Ann Surg Oncol. 2019 Mar;26(3):709-710. doi: 10.1245/s10434-018-07130-9. Epub 2019 Jan 2.
引用本文的文献
1
Cervical and breast cancer screening outcomes among Métis people in Alberta, Canada.加拿大艾伯塔省梅蒂斯人的宫颈癌和乳腺癌筛查结果。
BMC Womens Health. 2025 May 22;25(1):246. doi: 10.1186/s12905-025-03799-9.
2
Barriers to and facilitators of breast, cervical and colorectal cancer screening and cancer screening histories of Métis people in Alberta, Canada.加拿大艾伯塔省梅蒂斯人乳腺癌、宫颈癌和结直肠癌筛查的障碍和促进因素以及癌症筛查史。
Int J Circumpolar Health. 2024 Dec;83(1):2368766. doi: 10.1080/22423982.2024.2368766. Epub 2024 Jun 19.
3
Development and External Validation of Partial Proportional Odds Risk Prediction Models for Cancer Stage at Diagnosis among Males and Females in Canada.加拿大男性和女性癌症诊断时癌症分期的部分比例优势风险预测模型的开发与外部验证
Cancers (Basel). 2023 Jul 8;15(14):3545. doi: 10.3390/cancers15143545.
4
Treatment considerations for CAT.嗜酸性粒细胞性蜂窝织炎的治疗考量
Can Oncol Nurs J. 2023 Apr 1;33(2):288-2291. eCollection 2023 Spring.
5
[Not Available].[无可用内容]。
Can Oncol Nurs J. 2023 Apr 1;33(2):292-295. eCollection 2023 Spring.
6
Excellent summary of breast cancer recommendations.乳腺癌推荐的精彩总结。
Can Fam Physician. 2021 Mar;67(3):157-159. doi: 10.46747/cfp.6703157_1.
本文引用的文献
1
Low-Dose CT Screening for Lung Cancer: Evidence from 2 Decades of Study.低剂量 CT 筛查肺癌：来自 20 年研究的证据。
Radiol Imaging Cancer. 2020 Mar 27;2(2):e190058. doi: 10.1148/rycan.2020190058.
2
Projected estimates of cancer in Canada in 2020.2020 年加拿大癌症预估。
CMAJ. 2020 Mar 2;192(9):E199-E205. doi: 10.1503/cmaj.191292.
3
Colorectal cancer screening for patients with a family history of colorectal cancer or adenomas.结直肠癌患者有结直肠癌或腺瘤家族史的筛查。
Can Fam Physician. 2019 Nov;65(11):784-789.
4
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.加拿大胃肠病学协会管腔型克罗恩病管理临床实践指南
J Can Assoc Gastroenterol. 2019 Aug;2(3):e1-e34. doi: 10.1093/jcag/gwz019. Epub 2018 Jul 10.
5
Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.针对乳腺癌风险未增加的40至74岁女性乳腺癌筛查的建议。
CMAJ. 2018 Dec 10;190(49):E1441-E1451. doi: 10.1503/cmaj.180463.
6
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.前列腺癌筛查中前列腺特异性抗原（PSA）检测的系统评价和荟萃分析。
BMJ. 2018 Sep 5;362:k3519. doi: 10.1136/bmj.k3519.
7
Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.人乳头瘤病毒高危型检测用于宫颈癌筛查：美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2018 Aug 21;320(7):687-705. doi: 10.1001/jama.2018.10400.
8
Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.家族性非遗传性结直肠癌或腺瘤病史个体的结直肠癌筛查临床实践指南：加拿大胃肠病学协会班夫共识。
Gastroenterology. 2018 Nov;155(5):1325-1347.e3. doi: 10.1053/j.gastro.2018.08.017. Epub 2018 Aug 16.
9
Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.卵巢癌筛查：美国预防服务工作组推荐声明。
JAMA. 2018 Feb 13;319(6):588-594. doi: 10.1001/jama.2017.21926.
10
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.采用风险模型进行肺癌筛查的研究对象选择（泛加拿大肺癌早期检测[PanCan]研究）：一项单臂前瞻性研究。
Lancet Oncol. 2017 Nov;18(11):1523-1531. doi: 10.1016/S1470-2045(17)30597-1. Epub 2017 Oct 18.
Zotero 插件